REFERENCES
1. Brandt T, Dieterich M, Strupp M. Vertigo and Dizziness-Common
Complaints. second edition ed: Springer; 2013.
2. Crane B, T., Minor LB. Peripheral Vestibular Disorders. In: Flint P,
Haughey B, Lund V, Niparko J, Robbins K, Thomas JR, et al., editors.
Cummings Otolaryngology-Head and Neck Surgery. sixth edition ed:
Elsevier; 2015.
3. Jeong SH, Kim HJ, Kim JS. Vestibular neuritis. Semin Neurol .
2013;33(3):185-194.
4. Kitahara T, Kondoh K, Morihana T, Okumura S, Horii A, Takeda N, et
al. Steroid effects on vestibular compensation in human. Neurol
Res . 2003;25(3):287-291.
5. Fishman JM, Burgess C, Waddell A. Corticosteroids for the treatment
of idiopathic acute vestibular dysfunction (vestibular neuritis).Cochrane Database Syst Rev . 2011(5):Cd008607.
6. Ismail EI, Morgan AE, Abdel Rahman AM. Corticosteroids versus
vestibular rehabilitation in long-term outcomes in vestibular neuritis.J Vestib Res . 2018;28(5-6):417-424.
7. Sjogren J, Magnusson M, Tjernstrom F, Karlberg M. Steroids for Acute
Vestibular Neuronitis-the Earlier the Treatment, the Better the Outcome?Otol Neurotol . 2019;40(3):372-374.
8. Deeks JJ, Higgins J, Altman DG, Green S. Cochrane handbook for
systematic reviews of interventions version 5.1. 0 (updated March 2011).The Cochrane Collaboration . 2011:2.
9. Higgins JPT, Thomas, J., Chandler, J., Cumpston, M., Li, T., Page, M.
J., Welch, V. A. Cochrane Handbook for Systematic Reviews of
Interventions version 6.1 (updated September 2020). Cochrane,. 2020.
10. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P.
Reprint—preferred reporting items for systematic reviews and
meta-analyses: the PRISMA statement. Physical therapy .
2009;89(9):873-880.
11. Harris RJ, Deeks JJ, Altman DG, Bradburn MJ, Harbord RM, Sterne JA.
Metan: fixed-and random-effects meta-analysis. The Stata Journal .
2008;8(1):3-28.
12. Higgins JP, Thompson SG. Quantifying heterogeneity in a
meta‐analysis. Statistics in medicine . 2002;21(11):1539-1558.
13. Begg CB, Mazumdar M. Operating characteristics of a rank correlation
test for publication bias. Biometrics . 1994;50(4):1088-1101.
14. Ariyasu L, Byl FM, Sprague MS, Adour KK. The beneficial effect of
methylprednisolone in acute vestibular vertigo. Arch Otolaryngol
Head Neck Surg . 1990;116(6):700-703.
15. Shupak A, Issa A, Golz A, Margalit K, Braverman I. Prednisone
treatment for vestibular neuritis. Otol Neurotol .
2008;29(3):368-374.
16. Strupp M, Zingler VC, Arbusow V, Niklas D, Maag KP, Dieterich M, et
al. Methylprednisolone, valacyclovir, or the combination for vestibular
neuritis. New Engl J Med . 2004;351(4):354-361.
17. Yoo MH, Yang CJ, Kim SA, Park MJ, Ahn JH, Chung JW, et al. Efficacy
of steroid therapy based on symptomatic and functional improvement in
patients with vestibular neuritis: a prospective randomized controlled
trial. Eur Arch Otorhinolaryngol . 2017;274(6):2443-2451.
18. Strupp M, Zingler VC, Arbusow V, Niklas D, Maag KP, Dieterich M, et
al. Methylprednisolone, valacyclovir, or the combination for vestibular
neuritis. N Engl J Med . 2004;351(4):354-361.
19. Okinaka Y, Sekitani T, Okazaki H, Miura M, Tahara T. Progress of
caloric response of vestibular neuronitis. Acta Otolaryngol
Suppl . 1993;503:18-22.
20. Bergenius J, Perols O. Vestibular neuritis: a follow-up study.Acta Otolaryngol . 1999;119(8):895-899.
21. Choi KD, Oh SY, Kim HJ, Koo JW, Cho BM, Kim JS. Recovery of
vestibular imbalances after vestibular neuritis. Laryngoscope .
2007;117(7):1307-1312.
22. Hwang K, Kim BG, Lee JD, Lee ES, Lee TK, Sung KB. The extent of
vestibular impairment is important in recovery of canal paresis of
patients with vestibular neuritis. Auris Nasus Larynx .
2019;46(1):24-26.